Literature DB >> 18253828

Reduction of dendritic cells by granulocyte and monocyte adsorption apheresis in patients with ulcerative colitis.

Grit Waitz1, Sebastian Petermann, Stefan Liebe, Joerg Emmrich, Wolfgang Ramlow.   

Abstract

The influence of the granulocyte/monocyte apheresis (GMCAP) on cell populations participating in mechanisms of tolerance, e.g. dendritic cells (DCs), is still not very clear. In a first step, we aimed to investigate changes in the DC population of patients suffering from ulcerative colitis (UC) (n = 13) compared to healthy subjects (n = 9). In a second step, we studied the changes in peripheral DCs in a small group of patients with active UC before and after Adacolumn apheresis (n = 7). For this purpose, plasmacytoid and myeloid DCs and their maturation markers CD40, CD80, and CD86 were measured using four-color flow cytometry in the peripheral blood. After apheresis, and in acute flare-ups, we identified a significantly lower number of lymphocytes, plasmacytoid, and myeloid DCs. In conclusion, the additional removal of peripheral DCs by GMCAP, which otherwise would contribute to the inflammatory process in the gut, may lead to a higher tolerogeneic status towards luminal antigens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253828     DOI: 10.1007/s10620-007-0168-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors.

Authors:  Daniela Rozkova; Rudolf Horvath; Jirina Bartunkova; Radek Spisek
Journal:  Clin Immunol       Date:  2006-06-09       Impact factor: 3.969

Review 2.  Dendritic cells in the recognition of intestinal microbiota.

Authors:  Jan Hendrik Niess; Hans-Christian Reinecker
Journal:  Cell Microbiol       Date:  2006-04       Impact factor: 3.715

3.  Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis.

Authors:  Y Ikeda; F Akbar; H Matsui; M Onji
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-07       Impact factor: 2.566

4.  Critical role for serum opsonins and complement receptors CR3 (CD11b/CD18) and CR4 (CD11c/CD18) in phagocytosis of Francisella tularensis by human dendritic cells (DC): uptake of Francisella leads to activation of immature DC and intracellular survival of the bacteria.

Authors:  Abdelhakim Ben Nasr; Judith Haithcoat; Joseph E Masterson; John S Gunn; Tonyia Eaves-Pyles; Gary R Klimpel
Journal:  J Leukoc Biol       Date:  2006-07-20       Impact factor: 4.962

5.  Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.

Authors:  D C Baumgart; D Metzke; J Schmitz; A Scheffold; A Sturm; B Wiedenmann; A U Dignass
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

6.  Cellulose acetate beads induce release of interleukin-1 receptor antagonist, but not tumour necrosis factor-alpha or interleukin-1beta in human peripheral blood.

Authors:  Y Takeda; K Hiraishi; H Takeda; N Shiobara; H Shibusawa; A R Saniabadi; M Adachi; S Kawata
Journal:  Inflamm Res       Date:  2003-06       Impact factor: 4.575

7.  Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis.

Authors:  Mariusz Stasiolek; Antonios Bayas; Niels Kruse; Anja Wieczarkowiecz; Klaus V Toyka; Ralf Gold; Krzysztof Selmaj
Journal:  Brain       Date:  2006-03-02       Impact factor: 13.501

8.  Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.

Authors:  Jörg Emmrich; Sebastian Petermann; Dietrich Nowak; Ingolf Beutner; Peter Brock; Reinhard Klingel; Patrick Mausfeld-Lafdhiya; Stefan Liebe; Wolfgang Ramlow
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

9.  Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis.

Authors:  Nobuhito Kashiwagi; Kazuhito Sugimura; Hirobumi Koiwai; Hironori Yamamoto; Toshikazu Yoshikawa; Abby R Saniabadi; Masakazu Adachi; Takashi Shimoyama
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

10.  Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity.

Authors:  Florian Woelbing; Susanna Lopez Kostka; Katharina Moelle; Yasmine Belkaid; Cord Sunderkoetter; Sjef Verbeek; Ari Waisman; Axel P Nigg; Juergen Knop; Mark C Udey; Esther von Stebut
Journal:  J Exp Med       Date:  2006-01-17       Impact factor: 14.307

View more
  6 in total

Review 1.  Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults.

Authors:  Gerda C Leitner; Harald Vogelsang
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

2.  Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis.

Authors:  Shin-ichiro Takeda; Toru Sato; Tatsuro Katsuno; Tomoo Nakagawa; Yoshiko Noguchi; Osamu Yokosuka; Yasushi Saito
Journal:  Dig Dis Sci       Date:  2009-11-12       Impact factor: 3.199

3.  Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease.

Authors:  Gerda C Leitner; Nina Worel; Harald Vogelsang
Journal:  Transfus Med Hemother       Date:  2012-07-31       Impact factor: 3.747

Review 4.  Selective granulocyte and monocyte apheresis in inflammatory bowel disease: Its past, present and future.

Authors:  Xiu-Li Chen; Jing-Wei Mao; Ying-De Wang
Journal:  World J Gastrointest Pathophysiol       Date:  2020-05-12

5.  Therapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be?

Authors:  Maurizio Vecchi; Piero Vernia; Gabriele Riegler; Renata D'Incà; Vito Annese; Siro Bagnoli
Journal:  Clin Exp Gastroenterol       Date:  2013-01-04

6.  Exploratory Study of the Effectiveness of Granulocyte and Monocyte Adsorptive Apheresis Before Initiation of Steroids in Patients With Active Ulcerative Colitis (EXPECT Study): A Multicenter Prospective Clinical Trial.

Authors:  Kazuki Kakimoto; Minoru Matsuura; Takumi Fukuchi; Hitoshi Hongo; Tsuguhiro Kimura; Nobuo Aoyama; Yorihide Okuda; Kazuki Aomatsu; Noriko Kamata; Yoko Yokoyama; Chiemi Mizuno; Takuya Inoue; Takako Miyazaki; Shiro Nakamura; Kazuhide Higuchi; Hiroshi Nakase
Journal:  Crohns Colitis 360       Date:  2020-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.